VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, January 5, 2026
Stock Comparison
Legrand S.A. vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Legrand S.A.
LR · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Pfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Legrand S.A. leads (68 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Legrand S.A. has 2 segments (80% in Building electrical & digital infrastructure (non-datacenter)); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Moat breadth: Legrand S.A. has 4 moat types across 3 domains; Pfizer Inc. has 8 across 3.
Primary market context
Legrand S.A.
Building electrical & digital infrastructure (non-datacenter)
Low-voltage electrical and digital building infrastructure (wiring devices, energy distribution, cable management, building controls)
Global (strong Europe & North America footprint)
Professional installers/electricians, electrical wholesalers, OEM/contractors; end-users in residential & commercial buildings
Manufacturer + brand owner; channel-driven distribution
80%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
Legrand S.A. strengths
Pfizer Inc. strengths
Segment mix
Legrand S.A. segments
Full profile >Building electrical & digital infrastructure (non-datacenter)
Oligopoly
Datacenter infrastructure
Oligopoly
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.